ArticleEuropean journal of medical research2025
Joint association of inflammatory markers and sedentary time with mortality in metabolic dysfunction-associated steatotic liver disease population and the mediating role of inflammation.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of the RDW-to-albumin ratio with MAFLD and hepatic fibrosis in the U.S. population: a national cross-sectional study.Clinical and experimental medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundMetabolic dysfunction-associated steatotic liver disease (MASLD) is a growing public health burden globally, associated with multiple adverse outcomes and increased mortality. Sedentary behavior and systemic inflammation are independently linked to adverse outcomes, but their combined effects and potential interactions in the MASLD population remain unclear.
methodsWe used data from 10,778 U.S. adults with MASLD from NHANES 2007-2018. MASLD was identified using the Fatty Liver Index (FLI ≥ 60), a validated and widely applied noninvasive indicator of hepatic steatosis in NHANES-based epidemiologic studies, providing a reliable estimate of liver fat probability for population analyses. Sedentary time was assessed by questionnaire. The systemic inflammation response index (SIRI) was determined to be the most effective inflammatory marker among the 12 inflammatory indicators using time-dependent receiver operating characteristic curves. Weighted Cox proportional hazards models were used to evaluate associations with all-cause, cardiovascular disease (CVD), and cancer mortality. Restricted cubic spline (RCS) analysis was performed to assess nonlinear relationships. Joint associations and mediation analysis were conducted to explore joint effect and the mediating role of SIRI in the sedentary time-mortality relationship.
resultsA total of 1028 deaths occurred over the follow-up duration (median: 78 months), comprising 340 cardiovascular and 256 cancer-related. Longer sedentary time and elevated SIRI were independently associated with increased all-cause and CVD mortality. Compared with participants with low sedentary time and low SIRI, those with both high sedentary time (≥ 3.81 h/day) and high SIRI (≥ 0.81) had a 62% higher risk of all-cause mortality (HR 1.62, 95% CI 1.14-2.31) and a 137% higher risk of CVD mortality (HR 2.37, 95% CI 1.45-3.86). Mediation analysis showed that SIRI statistically explained 16.5% of the association between sedentary time and all-cause mortality and 14.7% of the association with CVD mortality.
conclusionsIn U.S. adults with a high probability of MASLD identified by the FLI, both longer sedentary time and elevated systemic inflammation level are linked to increased risks of all-cause and CVD mortality. Moreover, inflammation statistically explains part of this association. These findings highlight the importance of reducing sedentary time and managing systemic inflammation to improve outcomes in individuals with FLI-defined MASLD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.